1.
2.
Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism?
(feeds.feedburner.com)
3.
GLP-1 Users Are Being Cruelly Shamed by Their Own Families
(futurism.com)
4.
5.
The High-Risk Sprint to Superintelligence
(feeds.content.dowjones.io)
6.
The Race for the Next Big Weight-Loss Drug Is On—and China Wants In
(feeds.content.dowjones.io)
7.
Weight-loss drug slows ageing in female mice
(feeds.nature.com)
8.
Man loses so much weight employer doesn't recognize him
(news.ycombinator.com)
9.
10.
11.
12.
13.
14.
Study: Women are more likely to get hired after taking GLP-1s
(feeds.feedburner.com)
15.
16.
17.
19.
The GLP-1 paradox study: Here’s what people really think about your Ozempic weight loss
(feeds.feedburner.com)
20.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
21.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
22.
23.
24.
25.
With GLP‑1 drug ads everywhere, here’s what to know to safely buy them online
(feeds.feedburner.com)
26.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
27.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests
(feeds.feedburner.com)
28.
Python Blood Could Hold the Secret To Healthy Weight Loss
(slashdot.org)
29.
FDA approves higher-dose version of Wegovy shots
(feeds.feedburner.com)
30.